These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38836987)

  • 1. Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.
    Cocorpus J; Holman S; Yager JE; Helzner E; Sardar M; Kohlhoff S; Smith-Norowitz TA
    AIDS Behav; 2024 Sep; 28(9):2961-2969. PubMed ID: 38836987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data.
    Braunstein SL; Lazar R; Wahnich A; Daskalakis DC; Blackstock OJ
    Clin Infect Dis; 2021 Jun; 72(12):e1021-e1029. PubMed ID: 33252620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    Friedman EE; Devlin SA; McNulty MC; Ridgway JP
    PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
    Munasinghe LL; Yin W; Nathani H; Toy J; Sereda P; Barrios R; Montaner JSG; Lima VD
    Soc Sci Med; 2024 Jun; 350():116920. PubMed ID: 38703468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with HIV Viral Suppression in People Followed in an Outpatient Clinic in Angola During and After the COVID-19 Pandemic.
    Calcagno A; Pizzi C; Pocongo B; Ronzoni N; Alladio F; Francisco NM; Kalume A; Di Perri G; Gobbi F
    AIDS Patient Care STDS; 2024 Oct; 38(10):463-465. PubMed ID: 39364627
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 Testing Among People with HIV: A Population Level Analysis Based on Statewide Data in South Carolina.
    Shi F; Zhang J; Yang X; Gao H; Chen S; Weissman S; Olatosi B; Li X
    AIDS Behav; 2024 Oct; 28(Suppl 1):22-32. PubMed ID: 38109020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of people living with HIV hospitalised at tertiary healthcare institutions during the COVID-19 pandemic in Mexico City.
    Caro-Vega Y; Guerrero-Torres L; Cárdenas-Ortega A; Martin-Onraët A; Rodríguez-Zulueta P; Romero-Mora K; Schjetnan MG; Piñeirúa-Menéndez A
    BMC Infect Dis; 2024 May; 24(1):524. PubMed ID: 38789972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State.
    Tesoriero JM; Swain CE; Pierce JL; Zamboni L; Wu M; Holtgrave DR; Gonzalez CJ; Udo T; Morne JE; Hart-Malloy R; Rajulu DT; Leung SJ; Rosenberg ES
    JAMA Netw Open; 2021 Feb; 4(2):e2037069. PubMed ID: 33533933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPART.
    Loubet P; Lelievre JD; François A; Botelho-Nevers E; Chidiac C; Chirio D; Dubee V; Dussol B; Galtier F; Hessamfar M; Hodaj E; Jaffuel S; Lacombe K; Laine F; Lefebvre M; Maakaroun-Vermesse Z; Makinson A; Portefaix A; Pourcher V; Rey D; Zucman D; Longobardi J; Bertheau M; Tartour E; de Lamballerie X; Launay O; Wittkop L;
    Int J Infect Dis; 2024 Sep; 146():107110. PubMed ID: 38825164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
    PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in community viral load among HIV-infected persons in New York City.
    Laraque F; Mavronicolas HA; Robertson MM; Gortakowski HW; Terzian AS
    AIDS; 2013 Aug; 27(13):2129-39. PubMed ID: 24384591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SARS-CoV-2 pandemic on viral suppression for young adults living with perinatally acquired HIV infection.
    Hazell GA; Nott VR; Ayres S; Frize G; Kirkhope N; Fidler S; Foster C
    AIDS Care; 2024 Mar; 36(3):320-325. PubMed ID: 36007134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
    Casado-Fernández G; Cantón J; Nasarre L; Ramos-Martín F; Manzanares M; Sánchez-Menéndez C; Fuertes D; Mateos E; Murciano-Antón MA; Pérez-Olmeda M; Cervero M; Torres M; Rodríguez-Rosado R; Coiras M
    Front Immunol; 2024; 15():1362621. PubMed ID: 38812512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk indicators for oral ulcers among people living with HIV during the first wave of the pandemic: a cross sectional study.
    Folayan MO; Zuñiga RAA; Virtanen JI; Aly NM; Ezechi OC; Lusher J; El Tantawi M; Nguyen AL
    BMC Oral Health; 2023 Aug; 23(1):600. PubMed ID: 37635219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Telehealth Use in HIV Care During the COVID-19 Pandemic: Study Findings from South Carolina.
    Yelverton V; Ostermann J; Natafgi N; Olatosi B; Weissman S; Albrecht H
    Telemed J E Health; 2024 Jun; 30(6):1594-1599. PubMed ID: 38350120
    [No Abstract]   [Full Text] [Related]  

  • 18. Short Communication: HIV Viral Load Trends During the Coronavirus Disease 2019 Pandemic in a Reference Center for HIV in Rome, Italy.
    Latini A; Donà MG; Giuliani M; Pontone M; Ancona C; Foracappa S; Morrone A; Zaccarelli M
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):624-626. PubMed ID: 33966477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users.
    Campbell AN; Des Jarlais D; Hannah C; Braunstein S; Tross S; Kersanske L; Borges C; Pavlicova M; Jefferson K; Newville H; Weaver L; Wolff M
    BMC Health Serv Res; 2016 Aug; 16(a):341. PubMed ID: 27485435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of COVID-19 Pandemic on HIV Service Provision in Ukraine.
    Neduzhko O; Kiriazova T; Zeziulin O; Legkostup L; Riabokon S; DeHovitz JA; Dumchev K
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241277649. PubMed ID: 39252523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.